Literature DB >> 28501561

The sleeping ugly: Tumour microenvironment's act to make or break the spell of dormancy.

Laurie J Gay1, Ilaria Malanchi2.   

Abstract

Metastasis is the main cause of death for most cancer patients. It appears clear from clinical observations that the majority of cancers, particularly carcinoma do not follow a linear model of metastatic progression, where cancer cells shed from the primary tumour, disseminate to a distant organ and immediately outgrow to form clinical metastasis. Certainly, while cancer spreading is an early event, metastasis occurs much later during tumour progression and frequently arises several years after primary tumour resection. The time spent by disseminated cancer cells (DTCs) in a distant organ before their outgrowth is termed metastatic latency. We will examine here the current knowledge of the mechanisms allowing metastatic latency and discuss the crucial role of the DTCs' tissue microenvironment in this process.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2017        PMID: 28501561     DOI: 10.1016/j.bbcan.2017.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   11.414


  12 in total

Review 1.  Molecular principles of metastasis: a hallmark of cancer revisited.

Authors:  Jawad Fares; Mohamad Y Fares; Hussein H Khachfe; Hamza A Salhab; Youssef Fares
Journal:  Signal Transduct Target Ther       Date:  2020-03-12

Review 2.  Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.

Authors:  D Brooke Widner; Sun H Park; Matthew R Eber; Yusuke Shiozawa
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

Review 3.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 4.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

5.  Low Levels of Sox2 are required for Melanoma Tumor-Repopulating Cell Dormancy.

Authors:  Qiong Jia; Fang Yang; Wei Huang; Yao Zhang; Binghao Bao; Ke Li; Fuxiang Wei; Cunyu Zhang; Haibo Jia
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

Review 6.  Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells.

Authors:  Vincenzo Ingangi; Michele Minopoli; Concetta Ragone; Maria Letizia Motti; Maria Vincenza Carriero
Journal:  Front Oncol       Date:  2019-02-21       Impact factor: 6.244

Review 7.  The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.

Authors:  Amit S Yadav; Poonam R Pandey; Ramesh Butti; N N V Radharani; Shamayita Roy; Shaileshkumar R Bhalara; Mahadeo Gorain; Gopal C Kundu; Dhiraj Kumar
Journal:  Front Oncol       Date:  2018-03-19       Impact factor: 6.244

Review 8.  Mouse models of metastasis: progress and prospects.

Authors:  Laura Gómez-Cuadrado; Natasha Tracey; Ruoyu Ma; Binzhi Qian; Valerie G Brunton
Journal:  Dis Model Mech       Date:  2017-09-01       Impact factor: 5.758

Review 9.  EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?

Authors:  Keren Weidenfeld; Dalit Barkan
Journal:  Front Oncol       Date:  2018-09-12       Impact factor: 6.244

10.  Mitotic quiescence in hepatic cancer stem cells: An incognito mode.

Authors:  Kandasamy Ashokachakkaravarthy; Biju Pottakkat
Journal:  Oncol Rev       Date:  2020-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.